Association between matrix metalloproteinase 9 polymorphisms and breast cancer risk: An updated meta-analysis and trial sequential analysis

被引:9
|
作者
Xu, Tai [1 ,2 ]
Zhang, Siming [1 ]
Qiu, Dongqin [1 ]
Li, Xiaoyuan [1 ]
Fan, Yuanlin [1 ]
机构
[1] Meizhou Peoples Hosp, Dept Breast Surg, 63 Huangtang Rd, Meizhou 514000, Guangdong, Peoples R China
[2] Meizhou Peoples Hosp, Guangdong Prov Key Lab Precis Med & Clin Translat, Meizhou 514000, Guangdong, Peoples R China
关键词
Breast cancer; Matrix metalloproteinase 9; Polymorphism; Meta-analysis; MATRIX METALLOPROTEINASES; GENETIC POLYMORPHISMS; PROMOTER REGIONS; GELATINASE-B; MMP-9; STATISTICS; EXPRESSION; SUSCEPTIBILITY; PROGRESSION; SURVIVAL;
D O I
10.1016/j.gene.2020.144972
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Numerous studies have sought associations between matrix metalloproteinase 9 (MMP-9) polymorphisms and breast cancer risk. However, these studies have yielded conflicting results. Hence, we performed an updated meta-analysis to clarify the effects of four MMP-9 gene polymorphisms (rs3918242, rs2250889, rs3787268, and rs17576) on breast cancer risk. Methods: A comprehensive literature search for eligible studies was conducted in five electronic databases, including PubMed, Embase and Web of Science, up to March 1, 2020. Summary odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of associations in random-effects models. For the reduction of type I errors, a trial sequential analysis (TSA) was performed. Results: Twenty-one studies (8813 breast cancer cases and 9323 controls) were included in the quantitative analysis. For rs3918242, the overall ORs were significant under allelic comparison (OR (A vs. G) = 1.34; 95% CI 1.03, 1.74, P = 0.028) and the recessive genetic model (OR (AA vs. GG+GA) = 1.40; 95% CI 1.06, 1.84, P = 0.016). For rs2250889, the ORs were significant under homozygote comparison (OR (GG vs. CC) = 2.57; 95% CI 1.22, 5.42, P = 0.013), heterozygote comparison (OR (GC vs. CC) = 2.48; 95% CI 1.17, 5.23, P = 0.018), and the dominant genetic model (OR (GG+GC vs. CC) = 2.53; 95% CI 1.23, 5.20, P = 0.012). No associations were observed for rs3787268 or rs17576. The subgroup analyses indicated that the risk effect of the rs3918242 A allele was observed only among Asians. TSA showed that the findings for rs3918242, rs3787268, and rs17576 were robust, but many more patients are needed before definitive conclusions can be made for rs2250889. Conclusion: Our meta-analysis suggests that MMP-9 rs3918242, but not rs3787268 and rs17576 polymorphisms, may be risk factors for breast cancer. The effect of rs2250889 needs further confirmation with a larger sample size.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Association between PSCA gene polymorphisms and the risk of cancer: an updated meta-analysis and trial sequential analysis
    Qin, Zhiqiang
    Tang, Jingyuan
    Li, Xiao
    Yu, Yajie
    Zhang, Chuanjie
    Han, Peng
    Li, Ran
    Jiang, Xuping
    Yang, Chengdi
    Wang, Wei
    Tang, Min
    Zhang, Wei
    ONCOTARGET, 2017, 8 (31) : 51766 - 51778
  • [2] Association between the HOTAIR polymorphisms and cancer risk: an updated meta-analysis
    Zhang, Zhao-Xiong
    Tong, Xue
    Zhang, Wan-Ni
    Fu, Wei-Neng
    ONCOTARGET, 2017, 8 (03) : 4460 - 4470
  • [3] Association between Four MMP-9 Polymorphisms and Breast Cancer Risk: A Meta-Analysis
    Zhang, Xiaoli
    Jin, Guoyin
    Li, Jianfeng
    Zhang, Linxi
    MEDICAL SCIENCE MONITOR, 2015, 21 : 1115 - 1123
  • [4] Association Between Matrix Metalloproteinase-1, 2, 3 Polymorphisms and Oral Cancer Risk: A Meta-Analysis
    Li, Yingcai
    Wang, Yuqian
    Sun, Hongyan
    Zhang, Yan
    Li, Hui
    Cong, Xianling
    Yin, Wanzhong
    Song, Wenzhi
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2018, 22 (08) : 456 - 464
  • [5] MMP-9 gene polymorphisms on cancer risk: an updated systematic review and meta-analysis
    Teng, Zhihai
    Wang, Song
    Yuan, Hao
    Wang, Hu
    Li, Jingdong
    Chang, Xueliang
    Zhang, Yanping
    Han, Zhenwei
    Wang, Yaxuan
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2024, 43 (10) : 1090 - 1113
  • [6] The association of matrix metalloproteinase-9 promoter polymorphisms with gastric cancer risk: a meta-analysis
    Peng, Ziheng
    Jia, Jinhai
    Gong, Wenjian
    Gao, Xuehan
    Ma, Peiru
    Jin, Zhucheng
    Fan, Yue
    Li, Yanchu
    Zhang, Xiaolin
    ONCOTARGET, 2017, 8 (58) : 99024 - 99032
  • [7] Association between matrix-metalloproteinase polymorphisms and prostate cancer risk: a meta-analysis and systematic review
    Zhou, Hongxing
    Zhu, Xuming
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 5247 - 5259
  • [8] Significant Association of Matrix Metalloproteinase-9 Polymorphisms With Triple Negative Breast Cancer Risk
    Hung, Chih - chiang
    Wang, Yun - chi
    Shih, Hou - yu
    Liu, Chia - hua
    He, Jie - long
    Chen, Jaw - chyun
    Chang, Wen - shin
    Su, Chen - hsien
    Bau, Da - tian
    Tsai, Chia - wen
    CANCER GENOMICS & PROTEOMICS, 2025, 22 (02) : 258 - 270
  • [9] Current evidence on the relationship between four polymorphisms in the matrix metalloproteinases (MMP) gene and breast cancer risk: a meta-analysis
    Zhou, Ping
    Du, Liang-Feng
    Lv, Guo-Qiang
    Yu, Xian-Ming
    Gu, Yuan-Long
    Li, Jian-Ping
    Zhang, Chun
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 127 (03) : 813 - 818
  • [10] Association Between Matrix Metalloproteinase Family Gene Polymorphisms and Ischemic Stroke: a Meta-analysis
    Wen, Dan
    Du, Xin
    Nie, Shao-Ping
    Dong, Jian-Zeng
    Ma, Chang-Sheng
    MOLECULAR NEUROBIOLOGY, 2014, 50 (03) : 979 - 985